Science|Business Database: Coronavirus Funding Opportunities

This database is no longer being updated.

As a service to the global R&D community, Science|Business has compiled this database of funding opportunities. Users are encouraged to let us know of funding calls that could be incorporated into the database. Please email all suggestions to [email protected]. The database will be updated daily. For rapid news about COVID-19, see our live blog.

Urgent request for expressions of interest for extraordinary financing of research projects on sars-voc-2 and covid19 disease

Date added: 23 Apr 2020

Proposals must be appropriate to the emergency situation and, therefore, allow immediate implementation and start-up in the National Health System, with concrete, early results applicable to the current situation.

Amount
€24M
Agency or Funder
Carlos III Health Institute

The role of genomics in fighting COVID-19

Date added: 06 May 2020

Support for regional projects that use genomics to address specific, short-term needs of industry, not-for-profit bodies and the public sector in relation to COVID-19 through research in collaboration with these organisations.

Amount
Up to 250,000 CAD per region, total 1.5M CAD
Agency or Funder
Genome British Columbia
Eligibility (if available)

Regional organisations and researchers from Genome Centres

Foreign participation? (where known)
No

Advanced computing resources for research into COVID-19

Date added: 23 Apr 2020

PRACE, the Partnership for Advanced Computing in Europe, wants to hear how its resources can contribute to the mitigation of the impact of the COVID-19 pandemic.

Amount
Resources vary
Agency or Funder
Partnership for Advanced Computing in Europe
Eligibility (if available)

Academia, Research institutes, Commercial organisations based in Europe

Foreign participation? (where known)
Yes

Solutions for product supplies, vaccines, treatment and diagnosis

Date added: 12 May 2020

Projects should be able to be quickly implemented and focus on increasing supplies of products to deal with the pandemic, vaccines, improving COVID-19 treatment and diagnosis, and new public health measures.

Amount
€12M
Agency or Funder
Ministry of Science and Innovation
Eligibility (if available)

Companies and technology centres

Emergency response to COVID-19 in Peru (CLOSED)

Date added: 11 May 2020

Funding for innovative and low-cost solutions focused on COVID-19 diagnosis, treatment, epidemiology, PEE, and telehealth.

Amount
Up to PEN 350,000
Agency or Funder
Fondo Nacional de Desarrollo Científico y Tecnológico, Peru
Eligibility (if available)

Public and private Peruvian institutions, non-profits, universities, and international and foreign centres based in Peru

Foreign participation? (where known)
No

A Pandemic Response Challenge Program to meet COVID-19 related needs

Date added: 23 Apr 2020

Accelerate the development of diagnostics and medical countermeasures for a rapid front-line response to protect and treat Canadians.

Amount
C$15M
Agency or Funder
National Research Council of Canada
Eligibility (if available)

Researchers at Canadian and international universities, government departments, colleges, and highly innovative firms with relevant expertise.

Proposals invited for research into the novel coronavirus

Date added: 23 Apr 2020

A call for proposals for better understanding of diagnosis, prevention and management of the virus

Amount
£20 million
Agency or Funder
UK Research and Innovation & National Institute for Health Research (NIHR)
Eligibility (if available)

UK academia, industry experts and international partners

Foreign participation? (where known)
Yes
Date application deadline

Proven vaccine technologies, applicable for large scale manufacturing, for rapid response against novel coronavirus, 2019-nCoV

Date added: 23 Apr 2020

The objective of this Call for Proposals is to rapidly develop and manufacture a proven vaccine approach that can be used against the 2019-nCoV.

Agency or Funder
Norwegian Coalition for Epidemic Preparedness Innovations
Eligibility (if available)

Non-profit research organisations, for-profit companies, international organisations and foundations, joint R&D ventures, government research organisations, and academic institutions. Hold a vaccine technology that has already been proven. Propose only one 2019-nCoV vaccine candidate per application. Have the capacity to start vaccine manufacturing in at short notice. Be an organization that must be willing to transfer their vaccine technology to a global network
of large-scale manufacturers and ideally has its own large-scale manufacturing capabilities

Foreign participation? (where known)
Yes
Date application deadline

Rapid Response Call for "Active intervention development" and "Diagnosing and understanding COVID-19"

Date added: 23 Apr 2020

Research is to focus on vaccines and therapeutics; and on diagnostics, clinical investigations, anthropology investigations, and development of technologies, platforms or systems to accelerate the R&D of diagnostics.

Amount
£20M
Agency or Funder
National Institute for Health Research
Eligibility (if available)

Hosted by a UK institution eligible for UKRI funding. Overseas research organisations in affected countries providing important local engagement can be co-investigators

Foreign participation? (where known)
Yes
Date application deadline

IRHPA COVID 2020 Call

Date added: 23 Apr 2020

A special call specifically designed for COVID-19 and related respiratory viral infections to ramp up national R&D efforts for new antivirals, vaccines, and affordable diagnostics.

Amount
Not specified
Agency or Funder
Science & Engineering Research Board, India
Eligibility (if available)

One of the participating institutions should have access to Biosafety Level 3 and above facilities, along with expertise of handling respiratory viruses as per WHO/Govt. of India protocols.

Foreign participation? (where known)
No
Date application deadline

Support for vaccines, therapeutics and diagnostics that are scalable and have commercial potential – explicitly not a research fellowship: CLOSED

Date added: 23 Apr 2020

A call for proposals to accelerate development of diagnostics, vaccines, novel therapeutics and re-purposing of drugs

Amount
Budget depends on the proposed activities
Agency or Funder
Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC)
Eligibility (if available)

SMEs, Limited liability Partnership (LLP), Public or Private Research Institute, University and Non-academic Individuals.

Foreign participation? (where known)
No
Date application deadline

Funding opportunities on projects on AI and COVID-19: CLOSED

Date added: 23 Apr 2020

A targeted call for AI and COVID-19 interdisciplinary research collaborations to spark innovative, high-risk/high-reward ideas and projects

Amount
C$15,000
Agency or Funder
Canadian Institute for Advanced Research (CIFAR)
Eligibility (if available)

CIFAR Program Member or CIFAR AI Chair

Foreign participation? (where known)
Yes
Date application deadline

Fast-track grant for research on non-animal approaches to investigate mechanisms, medicines, and vaccines for COVID-19

Date added: 23 Apr 2020

The aim of the call is to gather information and stimulate funding of the development of non-animal, human biology-based models to help coordinate and accelerate responses to current and emerging pandemics

Amount
up to $40,000 (U.S. dollars)
Agency or Funder
Johns Hopkins Center for Alternatives to Animal Testing (CAAT)
Eligibility (if available)

Academic group, non-profit, or small or medium enterprise

Foreign participation? (where known)
Yes
Date application deadline

Transatlantic call for new coronavirus treatment proposals

Date added: 05 May 2020

A call for novel therapies, broad-spectrum antivirals, next-generation vaccines that may target new corona strains, multiple corona viruses or more than one type of virus, and strategies for first responders and emergency medical personnel.

Amount
$150.000 (U.S.) guaranteed, with the potential to receive up to $1 million
Agency or Funder
Harrington Discovery Institute
Eligibility (if available)

Project lead must have an MD, PhD or equivalent and based in the U.S., UK or Canada. 

Foreign participation? (where known)
Yes
Date application deadline

Grants available for researchers in Belgium

Date added: 23 Apr 2020

Funding to support reasearchers from FNRS and universities of the Wallonia-Brussels Federation. Priorities lie on epidemiological and translational studies, immunology and prevention of the virus.

Amount
€60,000
Agency or Funder
Fonds de la Recherche Scientifique (FNRS)
Eligibility (if available)

Researchers from FNRS or the six universities part of the Wallonia-Brussels Federation (ULB, UCLouvain, ULiege, UMons, UNamur, USL)

Foreign participation? (where known)
Yes
Date application deadline

Clinical and Translational Science Award (CTSA) Program is looking for applications to address informatics solutions

Date added: 23 Apr 2020

The proposals will focus on the use of informatics to advance COVID-19 diagnostics, therapeutics, and vaccines.

Agency or Funder
National Center for Advancing Translational Sciences (NCATS)
Foreign participation? (where known)
Yes
Date application deadline